Search
Patexia Research
Case number 1:24-cv-00249

American Regent, Inc. v. Somerset Therapeutics, LLC et al > Documents

Date Field Doc. No.Description (Pages)
Apr 5, 2024 N/A CASE CLOSED (dlw) (Entered: 04/05/2024) (0)
Apr 5, 2024 8 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (Attachments: # 1 Notice of Voluntary Dismissal)(as) (Entered: 04/05/2024) (0)
Apr 4, 2024 7 NOTICE of Voluntary Dismissal by American Regent, Inc. as to Without Prejudice (Viceconte, Christopher) (Entered: 04/04/2024) (2)
Feb 28, 2024 N/A Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:24-cv-00248-MN, 1:24-cv-00249-MN (rjb) (Entered: 02/28/2024) (0)
Feb 23, 2024 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Odin Pharmaceuticals, LLC, Somerset Pharma, LLC, Somerset Therapeutics, LLC ( Filing fee $ 405, receipt number ADEDC-4346189.) - filed by American Regent, Inc.. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet) (vfm) (Entered: 02/23/2024) (0)
Feb 23, 2024 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 02/23/2024) (3)
Feb 23, 2024 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/08/2024. Date of Expiration of Patent: 07/01/2041.Thirty Month Stay Deadline: 7/8/2026. (vfm) (Entered: 02/23/2024) (1)
Feb 23, 2024 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (vfm) (Entered: 02/23/2024) (1)
Feb 23, 2024 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo, Inc. and Daiichi Sankyo U.S. Holdings, Inc. for American Regent, Inc. Identifying Other Affiliate Daiichi Sankyo Company, Limited for American Regent, Inc. - filed by American Regent, Inc.. (vfm) (Entered: 02/23/2024) (2)
Feb 23, 2024 6 Summons Issued as to Odin Pharmaceuticals, LLC on 2/23/2024; Somerset Pharma, LLC on 2/23/2024; Somerset Therapeutics, LLC on 2/23/2024. (Attachments: # 1 Summons Issued Somerset Pharma, LLC, # 2 Summons Issued Odin Pharmaceuticals, LLC) (vfm) (Entered: 02/23/2024) (0)
Menu